
You are here :
Services >
In vitro CNS disease models
In vitro CNS disease models
In vitro screening of CNS drug candidates
Medium throughput screening on cortical cultures
Various Primary Cell Cultures: Cortex, Hippocampus, Raphe
Typical Neuroprotection Paradigm on primary culture

In vitro screening models available for neuroprotection
- Glutamate toxicity
- Hypoglycemia
- Anoxia

Map2 labeling (fluorescent labeling)
Outcome measures
- Automated quantification of the percentage of Map2 immunopositive surface (i.e. using the Cellomics® Imager)
- Counting the number of neurons
- High throughput analysis by qPCR
- Determination of EC50

More